Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,408.50
(
-1.24%
)
US TECH 100
28,244.40
(
-1.90%
)
Dow Jones
49,526.17
(
-1.07%
)
Brent Oil
106.70
(
0.00%
)
Bitcoin
78,163.21
(
-1.13%
)
News Focus
News Focus
Post# of 257579
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122988
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: genisi post# 68603

Saturday, 11/15/2008 3:04:34 PM

Saturday, November 15, 2008 3:04:34 PM

Post# of 257579
Re: Atripla quiz answer

>Chances are that a new drug will replace Sustiva in the Atripla combo even before it goes off patent in 2013 (that's when GILD will probably be ready with a generic version).<

Even if that were to happen, Atripla would not simply disappear and it would remain a very attractive target for genericization.

In other words, that’s an incorrect quiz answer, which is an uncommon sight for you :- )


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today